
    
      An Observational Study Evaluating the Long-Term Safety and Immunogenicity of HEPLISAV™
      compared with Engerix-B® in Adults with Chronic Kidney Disease who Have Previously Received
      At Least One Hepatitis B Vaccine Series
    
  